Mechanisms of Allergen Immunotherapy and Potential Biomarkers for Clinical Evaluation
Journal of Personalized Medicine · 17.05.2023 · 13 (5) · 845
DOI: 10.3390/jpm13050845 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Personalized Medicine, online erschienen am 17.05.2023. Verfasst von Umit M Sahiner und 8 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Allergy Unit, Department of Pediatrics, Hacettepe University School of Medicine, Hacettepe University Childrens Hospital, 06230 Ankara, Tur…. Die Arbeit wurde bisher 66-mal zitiert (Crossref) und nennt 113 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Allergen-immunotherapy (AIT) is an efficacious and disease-modifying treatment option for IgE-mediated diseases. Among these allergic rhinitis, insect venom allergy, food allergy, and allergic asthma are the most common candidates for AIT. AIT gives rise to clinical immunotolerance which may last for years after the treatment cessation. Mechanisms of AIT include suppression of allergic inflammation in target tissues and stimulation of the production of blocking antibodies, especially IgG4 and IgA. These mechanisms are followed by a reduction of underlying allergen-specific Th2 cell-driven responses to the allergens. Tolerance induction takes place through the desensitization of effector cells and stimulation of regulatory T cells that show their effects by mechanisms involving cell-cell cross-talk, but also other mechanisms, e.g., by the production of immunomodulatory cytokines such as, e.g., IL-10 and TGF-beta. From a personalized medical perspective, there is a need for clinical biomarkers of value in selecting responders and optimizing patient care during AIT. Also, a deeper understanding of underlying mechanistic processes will improve AIT’s future outcomes. In this paper, the current knowledge of mechanisms in AIT is reviewed with a special focus on biomarkers of this therapy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Pediatric Allergy Unit, Department of Pediatrics, Hacettepe University School of Medicine, Hacettepe University Childrens Hospital, 06230 Ankara, Turkey.
- Allergy Unit, Meyer Children's Hospital IRCCS, 50139 Florence, Italy.
- Department of Health Sciences, University of Florence, 50139 Florence, Italy.
- Departamento de Ciencias Médicas Básicas, Instituto de Medicina Molecular Aplicada (IMMA) Nemesio Díez, Facultad de Medicina, Universidad San PabloCEU, CEU Universities, 28668 Madrid, Spain.
- Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, 20090 Milan, Italy.
- Personalized Medicine, Asthma and Allergy, IRCCS Humanitas Research Hospital, Rozzano, 20089 Milan, Italy.
ORCID-Profile: Mattia Giovannini, Maria M Escribese, Giovanni Paoletti, Enrico Heffler, Domingo Barber, Oliver Pfaar
Zitieren
APA
Sahiner, U. M., Giovannini, M., Escribese, M. M., Paoletti, G., Heffler, E., Alvaro Lozano, M., Barber, D., Canonica, G. W., & Pfaar, O. (2023). Mechanisms of Allergen Immunotherapy and Potential Biomarkers for Clinical Evaluation. Journal of Personalized Medicine, 13(5), 845. https://doi.org/10.3390/jpm13050845
Vancouver
Sahiner UM, Giovannini M, Escribese MM, Paoletti G, Heffler E, Alvaro Lozano M, et al. Mechanisms of Allergen Immunotherapy and Potential Biomarkers for Clinical Evaluation. Journal of Personalized Medicine. 2023;13(5):845. doi:10.3390/jpm13050845
BibTeX
@article{Sahiner2023,
author = {Sahiner, Umit M and Giovannini, Mattia and Escribese, Maria M and Paoletti, Giovanni and Heffler, Enrico and Alvaro Lozano, Montserrat and Barber, Domingo and Canonica, Giorgio Walter and Pfaar, Oliver},
title = {Mechanisms of Allergen Immunotherapy and Potential Biomarkers for Clinical Evaluation},
journal = {Journal of Personalized Medicine},
year = {2023},
volume = {13},
number = {5},
pages = {845},
doi = {10.3390/jpm13050845}
}
EUVIMED